Delivery Order SPE2DB22D3501-SPE2DB25FWP47
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,329.44 to AmerisourceBergen Drug Corp for 10 mg vials of Imdelltra, a pharmaceutical product supporting federal medical procurement needs. The contract, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania....
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMDELLTRA 10 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price Delivery Order with a ceiling value of $30,988.32 and a period of performance through June 26, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,775.60 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of the same day. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order was placed for performance...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $16,222.44 to AmerisourceBergen Drug Corp under a firm fixed-price contract with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded delivery order represents a discrete task order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $179,628.39 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries no set-aside...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,264.06 to AmerisourceBergen Drug Corp on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,192.65 to AmerisourceBergen Drug Corp on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract valued at $1,688.08 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 22, 2025. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, PA. This delivery order is issued...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,688.46 to AmerisourceBergen Drug Corp on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded without set-aside designation,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $138,601.43 to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contractor, headquartered in Conshohocken,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWP47Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,034.66 to AmerisourceBergen Drug Corp for the supply of IMDELLTRA 1 MG vials. The contract is firm fixed price with an ultimate completion date of August 15, 2025, and represents a non-competitive, competitively awarded procurement. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the company's primary vehicle for supplying pharmaceuticals and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, leverages its comprehensive IDC to fulfill federal medical procurement requirements across multiple therapeutic domains. The company's portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical supplies distributed to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This specific delivery order for IMDELLTRA reflects the company's ongoing role as a critical vendor in the Defense Logistics Agency's pharmaceutical supply chain, with the DLA planning to establish additional regional pharmaceutical contracts under its Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/25/25 |